EVALUATING THE IMPACT OF MODERN ANTI-DIABETIC DRUGS ON SURVIVAL OUTCOMES IN LUNG CANCER PATIENTS WITH TYPE 2 DIABETES. JMHSR [Internet]. 2025 Jul. 17 [cited 2025 Jul. 24];2(3). Available from: https://jmhsr.com/index.php/jmhsr/article/view/457